Home > Compound List > Product Information
OBA-09 hydrate_Molecular_structure_CAS_856095-68-6(anhydrous))
Click picture or here to close

OBA-09 hydrate

Catalog No. SML0126 Name Sigma Aldrich
CAS Number 856095-68-6(anhydrous) Website http://www.sigmaaldrich.com
M. F. C10H10O6 Telephone 1-800-521-8956
M. W. 226.1828 Fax
Purity ≥98% (HPLC) Email
Storage desiccated Chembase ID: 155047

SYNONYMS

IUPAC name
2-[(2-oxopropanoyl)oxy]benzoic acid hydrate
IUPAC Traditional name
2-[(2-oxopropanoyl)oxy]benzoic acid hydrate
Synonyms
O-Pyruvoylsalicylic acid hydrate
2-(1,2-Dioxopropoxy)benzoic acid hydrate

DATABASE IDS

CAS Number 856095-68-6(anhydrous)
MDL Number MFCD20488062

PROPERTIES

Empirical Formula (Hill Notation) C10H8O5 · xH2O
Purity ≥98% (HPLC)
Apperance white to tan powder
Solubility DMSO: ≥24 mg/mL
MSDS Link Download
Storage Condition desiccated
Storage Temperature 2-8°C

DETAILS

Description (English)
Biochem/physiol Actions
OBA-09 is a neuroprotective agent. It is an ester of pyruvate and salicylic acid that acts as a multi-functional agent to protect against ischemic damages to the brain. Administration of 5 mpk OBA-09 following middle cerebral artery occlusion (MCAO) or oxygen-glucose deprivation (OGD) models of ischemic injury in rats prevents lipid peroxidation, ROS production and causes the recovery of NAD and ATP concentrations to near basal levels. The compound leads to reduction of infarct volume and also accelerates the recovery of behavioral and neurological deficits.
Description (简体中文)
Biochem/physiol Actions
OBA-09 is a neuroprotective agent. It is an ester of pyruvate and salicylic acid that acts as a multi-functional agent to protect against ischemic damages to the brain. Administration of 5 mpk OBA-09 following middle cerebral artery occlusion (MCAO) or oxygen-glucose deprivation (OGD) models of ischemic injury in rats prevents lipid peroxidation, ROS production and causes the recovery of NAD and ATP concentrations to near basal levels. The compound leads to reduction of infarct volume and also accelerates the recovery of behavioral and neurological deficits.

REFERENCES